All Products
Also known as
CN (abbreviation), Nervi cavernosi, Nervi erigentes (historical term), Penile erectile nerves, Parasympathetic erectile nerves, Cavernous nerve complex
Definition
Cavernous nerves are specialized parasympathetic nerve fibers that originate primarily from the pelvic plexus and play a crucial role in the erectile response mechanism1. These nerves contain both sympathetic fibers (originating at T11-L2 level) and parasympathetic fibers (originating at S2-S4 level) that branch from the pelvic plexus and intersect to form the cavernous nerve complex2. The cavernous nerves travel lateral to the prostatic fascia and join with several arteriovenous branches to form a thin neurovascular bundle (NVB), which is covered by the prostatic envelope3.
Upon sexual stimulation, these nerves release neurotransmitters, primarily nitric oxide (NO), which initiates the cascade of events leading to smooth muscle relaxation in the corpus cavernosum, increased arterial blood flow, and ultimately penile erection4. The parasympathetic activity of cavernous nerves counteracts the tonic sympathetic influence that maintains the penis in a flaccid state under normal conditions5. This delicate balance between parasympathetic and sympathetic innervation is essential for normal erectile function and sexual response6.
Clinical Context
Cavernous nerves are clinically significant in the context of erectile dysfunction (ED), particularly following pelvic surgeries1. Due to their anatomical location and proximity to the prostate, bladder, and rectum, these nerves are highly vulnerable to damage during surgical procedures2. Radical prostatectomy (RP) for prostate cancer is the most common cause of cavernous nerve injury (CNI), with studies showing that even with bilateral nerve-sparing techniques, some degree of nerve damage is inevitable3.
The incidence of ED following radical prostatectomy is estimated to be as high as 84.6% in patients with complete bilateral cavernous nerve resection and remains between 24-50% even after unilateral or bilateral nerve preservation attempts4. By 12 months post-surgery, erectile function fails to recover in over 70% of patients5. Other medical procedures that can damage cavernous nerves include transurethral resection of the prostate (TURP) for benign prostatic hyperplasia, radical cystectomy for bladder cancer, colorectal surgery, and radiotherapy for pelvic malignancies6.
Non-surgical causes of cavernous nerve injury include pelvic trauma, posterior urethral injuries, and metabolic conditions such as diabetes mellitus, which can cause neuropathy affecting these nerves7. Understanding the anatomy and function of cavernous nerves is essential for developing nerve-sparing surgical techniques and therapeutic interventions to preserve or restore erectile function in affected patients8.
Recent advances in neuroprotection and nerve regeneration strategies, including neuromodulatory proteins, gene therapy, stem cell therapy, and low-energy shock wave therapy, have shown promise in basic research and limited clinical studies for treating cavernous nerve injury-related erectile dysfunction9. These emerging approaches aim to preserve or restore cavernous nerve function and may represent future therapeutic options for patients with erectile dysfunction resulting from cavernous nerve damage10.